Treat fast but abandon time from ischemic stroke onset as a criterion for treatment: The DAWN and DEFUSE-3 trials.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1177/1747493018769004

Topics

  • Presentations referencing similar topics